Aktive farmaceutiske ingredienser
| Gestagen og østrogen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolon | In-house |
Kosher | 145-13-1 |
| Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
| Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproteronacetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
| Norethisteron |
CP/EP/USP/JP |
DMF i gang |
68-22-4 |
| Norethisteronacetat |
EP/USP |
DMF i gang |
51-98-9 |
| Norethisteron Enanthate |
In-house |
Under R&D |
3836-23-5 |
| Drospirenon | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Østradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
| Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
| Østradiol Valerat | CP/EP/USP/KP | DMF | 979-32-8 |
| Østradiol Cypionate |
USP | DMF i gang |
313-06-4 |
| Promestriene |
In-house |
Under R&D |
39219-28-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
| Exemestan | CP/EP/USP | Under R&D | 107868-30-4 |
| androgen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abirateronacetat | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamid |
In-house |
Under R&D |
1297538-32-9 |
| Testosteron | CP/EP/USP | CEP/FDA/WC | 58-22-0 |
| Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
| Testosteron Cypionate | USP | DMF | 58-20-8 |
| Testosteron Enanthate |
USP/JP | Under R&D |
315-37-7 |
| Testosteron propionat |
CP/EP/USP/JP |
Under R&D |
57-85-2 |
| DHEA | FP/In-house | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-house | DMF i gang | 19608-29-8 |
| Kortikalt hormon | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Budesonid | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonid | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenon | EP | CEP i gang | 107724-20-9 |
| Methylprednisolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
| Flutikasonfuroat | CP/EP | DMF i gang | 397864-44-7 |
| Mometasonfuroat |
CP/EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
| Deflazacort |
In-house |
Under R&D |
14484-47-0 |
| Andre | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepinacetat | CP/USP | DMF | 236395-14-5 |
| Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochlorid | USP/EP | CEP i gang | 175865-59-5 |
| Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
| Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
| Vibegron |
In-house |
Under R&D |
1190389-15-1 |
| Escitalopram Oxalat | CP/EP/USP | DMF i gang | 219861-08-2 |
| Citalopram Hydrobromid |
CP/EP/USP |
DMF i gang |
59729-32-7 |
| Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
| Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
| Luliconazol | In-house | DMF | 187164-19-8 |
| Nintedanib Esylate |
In-house |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Under R&D | 171596-29-5 |
| Relugolix | In-house | DMF i gang | 737789-87-6 |
| Ruxolitinib fosfat |
In-house |
DMF i gang |
1092939-17-7 |
| Abemaciclib |
In-house |
Under R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
| 1,3,5-trimethoxybenzen |
CP/In-house |
GMP |
621-23-8 |
| Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
| Tauroursodeoxycholsyre |
In-house |
Under R&D |
14605-22-2 |
| Kolesterol |
CP/EP/USP/JP |
Under R&D |
57-88-5 |
| Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
| Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
| Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
| Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
| Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
| Mellemmåltid |
In-house |
DMF i gang |
203787-91-1 |
Estradiol Valerat har CP-specifikation. DMF godkendt.
Estriol har CP, EP, USP specifikationer.DMF under arkivering.
Megestrolacetat har CP-, EP- og USP-specifikationer.DMF under arkivering.
Eplerenone har EP-specifikationer. CEP tilgængelig og FDA godkendt.
Fluticasonpropionat har CP-, EP- og USP-specifikationer.DMF tilgængelig.